Video Experimental Relacionado
Updated: Jun 29, 2026
09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
Los organoides del estriato específicos del paciente de la enfermedad de Parkinson muestran señales distintivas de un
Kyriaki Barmpa1, Claudia Saraiva1, Alise Zagare1
1Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Movement disorders : official journal of the Movement Disorder Society
|February 11, 2026
Resumen
Los organoides del estriado de la enfermedad de Parkinson (EP) muestran un fenotipo inflamatorio, lo que sugiere que la disfunción estriada, independiente de la dopamina, puede contribuir a la progresión de la EP. Este hallazgo pone de relieve el papel autónomo del estriado en la enfermedad.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Genética La genética.
- Biología de las células madre Biología de las células madre
Sus antecedentes:
- La degeneración de las neuronas dopaminérgicas en el estriado es central para la enfermedad de Parkinson (EP), pero las causas subyacentes siguen sin estar claras.
- El gen LRRK2, altamente expresado en el estriado, y su mutación G2019S están vinculados a la EP, lo que sugiere una posible participación estriada.
- La investigación de la función intrínseca estriatal puede revelar nuevos conocimientos sobre la patogénesis de la EP.
Objetivo del estudio:
- Para comparar los organoides del estriado derivados de pacientes sanos y de PD con la mutación LRRK2-G2019S.
- Para determinar si las alteraciones striatales, independientemente de la entrada dopaminérgica, contribuyen a la EP.
- Explorar el papel autónomo del estriado en el desarrollo de la EP.
Principales métodos:
- Generación y cultivo de organoides estriados derivados de células madre pluripotentes inducidas por humanos hasta el día 80.
- Evaluación de los niveles de proteínas específicas del estriado.
- Análisis de actividad proteómica y quinasa para evaluar cambios celulares y moleculares.
Principales resultados:
- Los organoides del estriado PD exhibieron niveles aumentados de DRD2, DARPP32 y CDK5.
- Los análisis de la actividad proteómica y de la quinasa revelaron un fenotipo inflamatorio en los organoides de la EP.
- La presencia de astrocitos reactivos confirmó la firma inflamatoria en los organoides del estriado PD.
Conclusiones:
- Los organoides del estriato modelan autónomamente los fenotipos relevantes para la PD, independientemente de la entrada dopaminérgica.
- Un fenotipo inflamatorio intrínseco en el estriado es una característica clave de los organoides de PD.
- Estos hallazgos sugieren que la disfunción estriatal juega un papel significativo y autónomo en la enfermedad de Parkinson.
Videos de Conceptos Relacionados
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...